Files
Download Full Text (363 KB)
Contents
- Immunotherapy for Genitourinary Cancers: Clinical trials explore immune checkpoint inhibitors for bladder, kidney, prostate cancers
- Active Surveillance for Ductal Carcinoma in Situ: COMET trial compares frequent mammography to standard treatment with surgery
- Radiation Plus Chemotherapy for Nasal NK T Cell Lymphoma: Clinical trial may standardize treatment for rare cancer
- HOUSE CALL: Mammography Is Essential for Breast cancer Screening- FDA warns against clinics that advertise screening without mammography
- USEFULRESOURCES: Videoconferences Allow Collaboration in Cancer Prevention, Treatment, Survivorship
Publication Date
1-1-2018
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Sharma, Padmanee; Gao, Jianjun; Subudhi, Sumit; Aparicio, Ana; Thompson, Alastair; Dabaja, Bouthaina S.; Bevers, Therese; Arora, Sanjeev; Urogenital Neoplasms; Immunotherapy; Clinical Trials as Topic; Immune Checkpoint Inhibitors; Carcinoma, Intraductal, Noninfiltrating; Watchful Waiting; Surgical Procedures, Operative; Lymphoma, Extranodal NK-T-Cell; Radiotherapy; Antineoplastic Agents; Mammography; Early Detection of Cancer; Breast Neoplasms; Nipple Aspirate Fluid; Videoconferencing.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Tutt, Bryan, "OncoLog, Volume 63, Number 01, January 2018" (2018). OncoLog MD Anderson's Report to Physicians (All issues). 286.
https://openworks.mdanderson.org/oncolog/286
Conditions Governing Access
Redacted